Literature DB >> 7579566

Stability of ifosfamide in solutions for multiday infusion by external pump.

L Leone1, A Comandone, C Oliva, P Bussi, F Goffredo, S Bretti, C Bumma.   

Abstract

The stability of ifosfamide in Ringer lactate buffer solution either alone or mixed with mesna at 37 degrees C for a 7-day period was analyzed by HPLC. This study was performed to investigate the feasibility of continuous infusion of ifosfamide by a multiday pump in order to reduce the toxicity and to increase the production of active alkylating metabolites of the parent drug. The total decay of ifosfamide activity did not exceed 3.2% at day 7. We conclude that ifosfamide can be safely delivered in a 7-day infusion with no significant loss of activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579566     DOI: 10.1097/00001813-199508000-00015

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  2 in total

1.  High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma.

Authors:  Roberta Sanfilippo; Rossella Bertulli; Andrea Marrari; Elena Fumagalli; Silvana Pilotti; Carlo Morosi; Antonella Messina; Angelo Paolo Dei Tos; Alessandro Gronchi; Paolo Giovanni Casali
Journal:  Clin Sarcoma Res       Date:  2014-11-22

2.  Clinical activity and tolerability of a 14-day infusional Ifosfamide schedule in soft-tissue sarcoma.

Authors:  Juan Martin-Liberal; Salma Alam; Anastasia Constantinidou; Cyril Fisher; Komel Khabra; Christina Messiou; David Olmos; Scott Mitchell; Omar Al-Muderis; Aisha Miah; Mark Linch; Robin L Jones; Michelle Scurr; Ian Judson; Charlotte Benson
Journal:  Sarcoma       Date:  2013-12-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.